Orlandella FM, Mariniello RM, Mirabelli P, De Stefano AE, et al. miR-622 is a novel potential biomarker of breast carcinoma and impairs motility of breast cancer cells through targeting NUAK1 kinase. Br J Cancer 2020 May 18. pii: 10.1038/s41416-020-0884.
PMID: 32418991